Lesson 6: History of the Development of Medications for Celiac Disease Lesson 5: Federal Funding and Drug Development Lesson 7: Why Endpoints Matter in Clinical Trials Back to: iAdvocate Policy Advocate Training > Innovations in Drug Development for Celiac Disease